Analystreport

Rhythm Pharmaceuticals (NASDAQ:RYTM) was given a new $129.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com